Comparison of patients who did and did not achieve CR
| Variable . | CR . | Non-CR . | P . | ||
|---|---|---|---|---|---|
| N . | Median (range) . | N . | Median (range) . | ||
| Age | 463 | 59.0 (18-84) | 334 | 63.5 (16-87) | .0002 |
| HGF | 65 | 805.4 (101.9-4176.1) | 36 | 1119.6 (298.7-12 819.5) | .06 |
| TNF-α | 65 | 8.6 (7.1-8.6) | 36 | 9.3 (7.2-48.2) | .05 |
| β2M | 301 | 2.4 (0.0-13.3) | 211 | 3.0 (0.8-31.3) | < .00001 |
| WBC | 463 | 6.4 (0.4-262.5) | 334 | 9.2 (0.2-266.0) | .17 |
| IL-1β | 60 | 2.5 (1.9-177.9) | 35 | 2.7 (2.1-25.9) | .01 |
| IL-1Ra | 60 | 471.3 (0-8 456.3) | 35 | 875.5 (53-7852.7) | .01 |
| IL-6 | 73 | 4.9 (2.3-261.1) | 41 | 5.6 (2.6-449.7) | .56 |
| Caspase 3 | 57 | 1.95 (0-22.3) | 33 | 3.47 (0-18.9) | .05 |
| Annexin in CD34+ | 10 | 6.48% (0%-33%) | 58 | 13.5% (0%-100%) | .03 |
| Variable . | CR . | Non-CR . | P . | ||
|---|---|---|---|---|---|
| N . | Median (range) . | N . | Median (range) . | ||
| Age | 463 | 59.0 (18-84) | 334 | 63.5 (16-87) | .0002 |
| HGF | 65 | 805.4 (101.9-4176.1) | 36 | 1119.6 (298.7-12 819.5) | .06 |
| TNF-α | 65 | 8.6 (7.1-8.6) | 36 | 9.3 (7.2-48.2) | .05 |
| β2M | 301 | 2.4 (0.0-13.3) | 211 | 3.0 (0.8-31.3) | < .00001 |
| WBC | 463 | 6.4 (0.4-262.5) | 334 | 9.2 (0.2-266.0) | .17 |
| IL-1β | 60 | 2.5 (1.9-177.9) | 35 | 2.7 (2.1-25.9) | .01 |
| IL-1Ra | 60 | 471.3 (0-8 456.3) | 35 | 875.5 (53-7852.7) | .01 |
| IL-6 | 73 | 4.9 (2.3-261.1) | 41 | 5.6 (2.6-449.7) | .56 |
| Caspase 3 | 57 | 1.95 (0-22.3) | 33 | 3.47 (0-18.9) | .05 |
| Annexin in CD34+ | 10 | 6.48% (0%-33%) | 58 | 13.5% (0%-100%) | .03 |